a change of the purposes of use of proceeds from IPO from the balance of working capital for business operations, which บริษัท ดีโอดี ไบโอเทค จ ำกัด (มหำชน) 111 หมู่ท่ี 2 ต ำบลท่ำจนี อ ำเภอเมืองสมุทร

derive a relatively higher rate of return. Moreover, the foregoing change of the purposes of use of proceeds will in no way affect the plan for use of the working capital for business operations because

level of the Company and subsidiaries to be consciousness and values in working with honesty, transparency, clarity and verifiability without any actions constitute to corruption directly and indirectly

: Overall Financial Performance Unit: million baht Jan-Dec 2018 % Jan-Dec 2019 % Change % YoY Revenue 523.23 100.0% 613.86 100.0% 90.63 17.3% Cost 285.52 54.6% 332.39 54.1% 46.87 16.4% Gross Profit 237.71

1: Overall Financial Performance Unit: mb Q1 18 % Q1 19 % Change % YoY Revenue 131.45 100.0% 132.54 100.0% 1.09 0.8% Cost 75.00 57.1% 73.41 55.4% (1.59) (2.1%) Gross Profit 56.45 42.9% 59.13 44.6

and cash equivalents in the amount of THB 450.39 million. This was pursuant to the Company’s policy in maintaining liquidity and setting aside cash reserves to be used as working capital in order to

Table 1: Overall Financial Performance Unit: million baht Jan-Sep 2018 % Jan-Sep 2019 % Change % YoY Revenue 380.50 100.0% 440.78 100.0% 60.28 15.8% Cost 217.33 57.1% 238.03 54.0% 20.70 9.5% Gross Profit

) amounting of 120,000,000 shares as par value of Baht 0.50 (after conversion to a Public Company Limited, UAPC will change par value from 100 Baht to 0.50 Baht) or equivalent to 25.00 percent of Total Paid-up

. In this regard, the Board and the senior management may appoint a working group as a responsible person for operational works, but they shall keep monitoring such operations. Division 3 Impacts from

business continuity plan (Business Continuity Plan: BCP) which is consistent with the policy stipulated in (1) approved by senior management and board of directors or working group that is assigned in